127 related articles for article (PubMed ID: 8345813)
1. Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients.
Dupré J; Behme MT; Hramiak IM; Longo CJ
Metabolism; 1993 Aug; 42(8):921-7. PubMed ID: 8345813
[TBL] [Abstract][Full Text] [Related]
2. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
Nauck MA; Homberger E; Siegel EG; Allen RC; Eaton RP; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1986 Aug; 63(2):492-8. PubMed ID: 3522621
[TBL] [Abstract][Full Text] [Related]
3. Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion.
Hampton SM; Morgan LM; Tredger JA; Cramb R; Marks V
Diabetes; 1986 May; 35(5):612-6. PubMed ID: 3514335
[TBL] [Abstract][Full Text] [Related]
4. Effect of the enteroinsular axis on both the A- and B-cell response to arginine after oral glucose in man.
Shimizu I; Hirota M; Ohboshi C; Mizuno A; Shima K
Diabetologia; 1987 Nov; 30(11):846-50. PubMed ID: 3328720
[TBL] [Abstract][Full Text] [Related]
5. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
6. Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet.
Morgan LM; Hampton SM; Tredger JA; Cramb R; Marks V
Br J Nutr; 1988 May; 59(3):373-80. PubMed ID: 3293660
[TBL] [Abstract][Full Text] [Related]
7. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
8. Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs.
Chap Z; Ishida T; Chou J; Lewis R; Hartley C; Entman M; Field JB
J Clin Invest; 1985 Sep; 76(3):1174-81. PubMed ID: 3900134
[TBL] [Abstract][Full Text] [Related]
9. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
Nauck M; Stöckmann F; Ebert R; Creutzfeldt W
Diabetologia; 1986 Jan; 29(1):46-52. PubMed ID: 3514343
[TBL] [Abstract][Full Text] [Related]
10. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B
J Clin Endocrinol Metab; 2011 Aug; 96(8):2519-24. PubMed ID: 21593115
[TBL] [Abstract][Full Text] [Related]
11. Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats.
Kissler HJ; Gepp H; Schmiedl A; Schwille PO
Metabolism; 1999 May; 48(5):645-50. PubMed ID: 10337868
[TBL] [Abstract][Full Text] [Related]
12. The effect of oral galactose on GIP and insulin secretion in man.
Morgan LM; Wright JW; Marks V
Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694
[TBL] [Abstract][Full Text] [Related]
13. The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).
Meier JJ; Gallwitz B; Siepmann N; Holst JJ; Deacon CF; Schmidt WE; Nauck MA
Regul Pept; 2003 May; 113(1-3):95-100. PubMed ID: 12686467
[TBL] [Abstract][Full Text] [Related]
14. Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine.
Dupre J; Jenner MR; Mahon JL; Purdon C; Rodger NW; Stiller CR
Diabetes; 1991 May; 40(5):598-604. PubMed ID: 2022304
[TBL] [Abstract][Full Text] [Related]
15. The effect of galanin on canine plasma glucose and gastroenteropancreatic hormone responses to oral nutrients and intravenous arginine.
McDonald TJ; Dupre J; Greenberg GR; Tepperman F; Brooks B; Tatemoto K; Mutt V
Endocrinology; 1986 Nov; 119(5):2340-5. PubMed ID: 2429832
[TBL] [Abstract][Full Text] [Related]
16. Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion.
Eaton RP; Allen RC; Schade DS
J Clin Endocrinol Metab; 1983 Jun; 56(6):1294-300. PubMed ID: 6341392
[TBL] [Abstract][Full Text] [Related]
17. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
Kruszynska YT; Ghatei MA; Bloom SR; McIntyre N
Hepatology; 1995 Apr; 21(4):933-41. PubMed ID: 7705803
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
[TBL] [Abstract][Full Text] [Related]
19. Oral glucose decreases hepatic extraction of insulin.
Gibby OM; Hales CN
Br Med J (Clin Res Ed); 1983 Mar; 286(6369):921-3. PubMed ID: 6403135
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
